SBA Academy: Challenges in Drug Discovery and Development

Module 2: Nonclinical Development - CHF 150.00 for members of SBA, swiTT, CTI-start-up companies and academia. This seminar day will focus on Pre-Clinical Studies - special attention is given to needs and challenges of biotech SMEs.
For more information click here

Start Date 22.03.2013 - 09:00
Event End 22.03.2013 - 17:00
Location EPFL Lausanne

Module 2: Nonclinical Development

CHF 150.00 for members of SBA, swiTT, CTI-start-up companies and academia

This seminar day will focus on Pre-Clinical Studies - special attention is given to needs and challenges of biotech SMEs:

  • Pharma R&D: Issues and Perspectives (Kamel Besseghir, Debiopharm)
  • Early Safety Tests (Manfred Schneider, Consultant)
    Case Presentation (Hasnaa Haddouk, Addex)
  • Toxicity Studies:
    Relevant Issues in Toxicity Studies (Rüdiger Häcker, Harlan Laboratories)
    Case Presentation (Carlo Chiavaroli, Voisin)
  • Bioanalysis and DMPK studies
    Bioanalysis, Drug Metabolism and Pharmacokinetics in Drug Development: a Regulatory and Industrial Perspective (Valérie Nicolas, Debiopharm)
    Case Presentation (Sorana Greiveldinger-Poenaru, Swiss Bioanalytics)
  • Keynote: Issues in Quality Assurance (Claude Ammann, Consultant)

For more information click here